Cargando…
Malignant mesothelioma: Canadian perspective and research directions
Since the 1960s, the incidence of malignant mesothelioma in Canada has increased dramatically because of work-related asbestos exposures. Treatment options are limited. Although chemotherapy is now an accepted standard in the management of advanced disease, uncertainty surrounds the roles of radical...
Autores principales: | Lee, C.W., Martin, J., MacRae, R., Tsao, M.S., Nguyen, E., Johnston, M., Baas, P., Laurie, S., Feld, R., Murray, N., Shepherd, F.A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Multimed Inc.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365488/ |
Ejemplares similares
-
Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020) -
Tumor volume is an independent predictor of survival in patients with malignant pleural mesothelioma
por: Kircheva, Diana Y, et al.
Publicado: (2015) -
Editorial: Emerging Therapies for Malignant Mesothelioma
por: van Zandwijk, Nico, et al.
Publicado: (2020) -
Malignant mesothelioma
por: Ruffié, P, et al.
Publicado: (2001) -
The observed incidence of anaphylaxis and serum sickness in patients receiving omalizumab in a tertiary allergy and asthma clinic in Canada
por: MacRae, Megan, et al.
Publicado: (2014)